Background: Portal lymphadenectomy (PLND) is the current standard for oncologic resection of biliary tract cancers (BTCs). However, published data show it is performed infrequently and often yields less than the recommended 6 lymph nodes. We sought to identify yield and outcomes using a Clockwise Anterior-to-Posterior technique with Double Isolation of critical structures (CAP-DI) for PLND. Methods: Consecutive patients undergoing complete PLND for BTCs using CAP-DI technique were identified (2015−2021). Lymph node (LN) yield and predictors of LN count were examined. Secondary outcomes included intraoperative and postoperative outcomes, which were compared to patients having hepatectomy without PLND. Results: In total, 534 patients were included; 71 with complete PLND (36 gallbladder cancers, 24 intrahepatic cholangiocarcinomas, 11 perihilar cholangiocarcinomas) and 463 in the control group. The median PLND yield was 5 (IQR 3−8; range 0−17) and 46% had at least 6 nodes retrieved. Older age was associated with lower likelihood of ≥6 node PLND yield (p = 0.032), which remained significant in bivariate analyses with other covariates (p < 0.05). After adjustment for operative factors, performance of complete PLND was independently associated with longer operative time (+46.4 min, p = 0.001), but no differences were observed in intraoperative or postoperative outcomes compared to the control group (p > 0.05). Conclusions: Yield following PLND frequently falls below the recommended minimum threshold of 6 nodes despite a standardized stepwise approach to complete clearance. Older age may be weakly associated with lower PLND yield. While all efforts should be made for complete node retrieval, failure to obtain 6 nodes may be an unrealistic metric of surgical quality.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738406PMC
http://dx.doi.org/10.3390/cancers14235770DOI Listing

Publication Analysis

Top Keywords

complete plnd
12
plnd yield
12
plnd
10
portal lymphadenectomy
8
biliary tract
8
yield outcomes
8
intraoperative postoperative
8
postoperative outcomes
8
outcomes compared
8
control group
8

Similar Publications

Article Synopsis
  • The investigation focused on high-risk prostate cancer patients receiving neoadjuvant therapy before surgical procedures to assess clinical outcomes and factors influencing pathological responses.
  • 76 patients were analyzed after receiving either androgen deprivation therapy with apalutamide or abiraterone, revealing significant differences in rates of pathological complete response and biochemical recurrence duration.
  • Results showed that the apalutamide group had higher rates of complete response (51.5% vs. 25.6%) and longer biochemical recurrence duration (261 days vs. 76 days), with lower post-treatment PSA levels being a key predictor of favorable outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Pelvic lymph node dissection (PLND) is an important part of radical prostatectomy for prostate cancer but can lead to complications; this study analyzed its effectiveness.
  • A retrospective analysis of 1,474 patients found that 64.9% underwent PLND and 16.6% had lymph node metastasis, with extended PLND showing a higher positive rate for lymph nodes than the obturator resection group.
  • The findings suggest that extended PLND can enhance detection of positive lymph nodes, leading to better guidance for follow-up treatments, and overall survival rates were similar between groups with and without PLND.
View Article and Find Full Text PDF
Article Synopsis
  • Partial cystectomy (PC) can be beneficial for some patients with muscle-invasive bladder cancer (MIBC), but its effectiveness may be limited if standard treatments like neoadjuvant chemotherapy (NAC) and pelvic lymph node dissection (PLND) aren’t used.
  • A study involving 2,832 patients found that those who received NAC with PLND had significantly better overall survival (OS) compared to those treated with just PC, with median OS of 76.5 months for PLND only and not reached for the combination therapy.
  • Factors such as private insurance, receiving NAC, and sufficient lymph node removal positively impacted OS, while older age, higher comorbidity index, and
View Article and Find Full Text PDF

Background: Recently, an innovative tool called "proficiency score" was introduced to assess the learning curve for robot-assisted radical prostatectomy (RARP). However, the initial study only focused on patients with low-risk prostate cancer for whom pelvic lymph node dissection (PLND) was not required. To address this issue, we aimed to validate proficiency scores of a contemporary multicenter cohort of patients with high-risk prostate cancer treated with RARP plus extended PLND by trainee surgeons.

View Article and Find Full Text PDF

Introduction: Although the clinical benefits of pelvic lymph node dissection (PLND) at the time of radical prostatectomy for prostate cancer remain uncertain, major guidelines recommend PLND based on risk profile. Thus, the objective of this study was to examine the association between PLND and survival among patients undergoing RP stratified by Gleason grade group (GG) with the aim of allowing patients and physicians to make more informed care decisions about the potential risks and benefits of PLND.

Materials And Methods: From the SEER-17 database, we examined overall (OS) and prostate cancer-specific (PCSS) survival of prostate cancer patients who underwent RP from 2010 to 2015 stratified by GG.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!